A unique study tracking EU-5 patients’ perceptions, experiences and awareness on their treatments for Rheumatology, Dermatology and Gastroenterology conditions.
Biologics and Biosimilars Barometer
25 000,00 €
France, Germany, Italy, Spain, UK
Pan European report with 150+ pages of in-depth analysis and recommandations.
Ad hoc online research. All of Carenity’s community with conditions in scope were invited to participate by email: rheumatology (Rheumatoid Arthritis, Ankylosing Spondylitis), gastroenterology (Crohn’s disease, Ulcerative colitis) and dermatology (Psoriasis, Psoriatic Arthritis).
Annual subscription – 1 wave / year
Assess patient’s awareness and perception of biologics/biosimilars
Understand patients’ expectations on support and information
Evaluate patients’ perception of current biologics
Assess manufacturers awareness